| 产品详情 |
| Edit |   |
|---|
| Product Name | SirtACt |
|---|
| Description | SirtAct is a potent Sirtuin 1 (SIRT1) activator. It increases fluorescence by 233% in a SIRT1 activity assay. SIRT1 stimulation by SirtAct leads to decreased tissue factor mediated thrombogenicity in mice. It inhibits NF-κB activation and reduces inflammatory cytokine production in lamina propria mononuclear cells from IBD patients. SirtAct also prevents and cures experimental colitis in a mouse model. MW: 367.5. Purity ≥98% by TLC |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 2-?Amino-?N-?cyclopentyl-?1-?(3-?methoxypropyl)-?1H-?pyrrolo[2,?3-?b]quinoxaline-?3-?carboxamide; CAY10591; SIRT1 activator 3; Sirtuin1 Activator 3 |
|---|
| Gene, Accession, CAS # | CAS: 839699-72-8 |
|---|
| Catalog # | 2741-10 |
|---|
| Price | |
|---|
| Order / More Info | SirtACt from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|